TPG Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$529K Buy
575
+16
+3% +$16.2K 0.33% 56
2025
Q4
$601K Hold
559
0.37% 45
2025
Q3
$427K Sell
559
-1
-0.2% -$744 0.28% 60
2025
Q2
$437K Hold
560
0.32% 53
2025
Q1
$463K Sell
560
-40
-7% -$33.3K 0.36% 44
2024
Q4
$463K Sell
600
-1
-0.2% -$828 0.36% 45
2024
Q3
$532K Hold
601
0.42% 42
2024
Q2
$544K Buy
+601
New +$481K 0.46% 42

Other funds holding LLY

TPG Advisors's LLY Position: Q1 2026 in Review

TPG Advisors increased its Eli Lilly (LLY) stake by 2.9% in Q1 2026, buying an estimated $16.2K and bringing the position to 575 shares worth $529K. The position accounts for 0.33% of the portfolio, ranked #56.

TPG Advisors first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $601K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • TPG Advisors held 575 shares of Eli Lilly worth $529K as of Q1 2026.
  • TPG Advisors bought 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.33% of TPG Advisors's portfolio in Q1 2026, its #56 holding.
  • TPG Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • TPG Advisors's Eli Lilly position peaked at $601K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on TPG Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.